Report overview
This report contains market size and forecasts of Companion Diagnostics (CDx) Development Services in Global, including the following market information:
Global Companion Diagnostics (CDx) Development Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Companion Diagnostics (CDx) Development Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Feasibility Studies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Companion Diagnostics (CDx) Development Services include Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, Quest Diagnostics, Q? Solutions, ResearchDx, Almac Diagnostic Services, Biocartis and Cerba Research, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Companion Diagnostics (CDx) Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Companion Diagnostics (CDx) Development Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Companion Diagnostics (CDx) Development Services Market Segment Percentages, by Type, 2021 (%)
Feasibility Studies
Assay Development
Analytical Validation
Clinical Validation
Others
Global Companion Diagnostics (CDx) Development Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Companion Diagnostics (CDx) Development Services Market Segment Percentages, by Application, 2021 (%)
Infectious Diseases
Neurological Disorders
Global Companion Diagnostics (CDx) Development Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Companion Diagnostics (CDx) Development Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Companion Diagnostics (CDx) Development Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Companion Diagnostics (CDx) Development Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Geneuity-Clinical Research Services
Interpace Biosciences
Labcorp
Quest Diagnostics
Q? Solutions
ResearchDx
Almac Diagnostic Services
Biocartis
Cerba Research
Eurofins Scientific
MLM Medical Labs
Qiagen
BGI Genomics
MEDx Translational Medicine
Medical Biological Laboratories (MBL)
Novogene
